insights_auto
Why is MGX up 2,80%?
Dive Deeperchevron_right
MGX:NASDAQ
Metagenomi Therapeutics Inc
US$1,05
arrow_upward
+2,80%(+0,029) 1D
5 ຕ.ລ., 10 ໂມງ 37 ນາທີ 02 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MGX...
Open
US$1,01
High
US$1,06
Low
US$1,01
Mkt. cap
39,61 ລ້ານ
Avg. vol.
149,72 ພັນ
Volume
43,56 ພັນ
52-wk high
US$3,95
52-wk low
US$1,01
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
Open
US$1,01
High
US$1,06
Low
US$1,01
Mkt. cap
39,61 ລ້ານ
Avg. vol.
149,72 ພັນ
Volume
43,56 ພັນ
52-wk high
US$3,95
52-wk low
US$1,01
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
News stories
From web sources and news partners
GlobeNewswire
·
44 ນາທີກ່ອນ
LKQ Corporation to Release Third Quarter 2026 Results on Thursday, October 29, 2026
www.marketscreener.com
·
1 ຊົ່ວໂມງກ່ອນ
Mobix Labs (Nasdaq: MOBX) Acquisition Target SPD to Acquire Winner Water, U.S. Rare Earth Company Backed by $53 Million in Federal Awards
Yahoo Finance Singapore
·
1 ຊົ່ວໂມງກ່ອນ
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
Reuters
·
1 ຊົ່ວໂມງກ່ອນ
Wall St opens muted as tech stocks take a breather
About Metagenomi Therapeutics Inc
CEO-
Employees113
Founded2016
HeadquartersEmeryville, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitemetagenomi.co